Does GILTERITINIB Cause Febrile neutropenia? 346 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 346 reports of Febrile neutropenia have been filed in association with GILTERITINIB (Xospata). This represents 9.4% of all adverse event reports for GILTERITINIB.
346
Reports of Febrile neutropenia with GILTERITINIB
9.4%
of all GILTERITINIB reports
115
Deaths
235
Hospitalizations
How Dangerous Is Febrile neutropenia From GILTERITINIB?
Of the 346 reports, 115 (33.2%) resulted in death, 235 (67.9%) required hospitalization, and 59 (17.1%) were considered life-threatening.
Is Febrile neutropenia Listed in the Official Label?
Yes, Febrile neutropenia is listed as a known adverse reaction in the official FDA drug label for GILTERITINIB.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
Neutrophil count decreased (162)
What Other Drugs Cause Febrile neutropenia?
CYCLOPHOSPHAMIDE (11,318)
DOXORUBICIN (8,844)
VINCRISTINE (8,676)
RITUXIMAB (6,382)
CYTARABINE (6,142)
METHOTREXATE (6,091)
ETOPOSIDE (5,966)
CARBOPLATIN (4,888)
DEXAMETHASONE (4,382)
PREDNISONE (3,956)
Which GILTERITINIB Alternatives Have Lower Febrile neutropenia Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB